Where Will Gilead Sciences Be in 1 Year?

Gilead Sciences (NASDAQ:GILD) has become a rather peculiar stock this year. On the one hand, the company has many investors excited about its coronavirus treatment, Veklury. On the other, its stock has fallen about 5% year to date, far underperforming the S&P 500's 17% total gain during the same period.